Autologous immune enhancement therapy in Philadelphia chromosome positive acute lymphoblastic leukemia.

about

Autologous immune enhancement therapy in Philadelphia chromosome positive acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q41869977

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Autologous immune enhancement ...... acute lymphoblastic leukemia.

@en

type

Item

label

Autologous immune enhancement ...... acute lymphoblastic leukemia.

@en

prefLabel

Autologous immune enhancement ...... acute lymphoblastic leukemia.

@en

P1476

Autologous immune enhancement ...... acute lymphoblastic leukemia.

@en

P2093

G Vimal Kumar

http://www.w3.org/2001/XMLSchema#string

Karuna Sri

http://www.w3.org/2001/XMLSchema#string

M Deenadayalan

http://www.w3.org/2001/XMLSchema#string

Rajappa Senthilkumar

http://www.w3.org/2001/XMLSchema#string

Revathi Raj

http://www.w3.org/2001/XMLSchema#string

Samuel J K Abraham

http://www.w3.org/2001/XMLSchema#string

Terunuma Hiroshi

http://www.w3.org/2001/XMLSchema#string

Vipin Khandelwal

http://www.w3.org/2001/XMLSchema#string

P2860

Autologous immune enhancement therapy in recurrent ovarian cancer with metastases: a case report

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial.

Natural killer cell-based therapies.

A comparative analysis of in vitro expansion of natural killer cells of a patient with autoimmune haemolytic anaemia and ovarian cancer with patients with other solid tumours.

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.

NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies.

A report of three patients treated with immunocell therapy with imatinib mesylate.

Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer.

Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach.

P2888

s12288-013-0327-3

P304

202-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S12288-013-0327-3

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029587929

http://www.w3.org/2001/XMLSchema#string

P698

25332578

http://www.w3.org/2001/XMLSchema#string

P932

4192214

http://www.w3.org/2001/XMLSchema#string